Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Elixir Medical
AddedFeb 15, 2024
UpdatedJun 18, 2026
Elixir Medical

Elixir Medical

Series A

Sunnyvale-based Elixir Medical Corp. develops advanced medical devices and pharmaceuticals for effective cardiovascular treatment.

HQ
Sunnyvale, CA, US
Founded
2004
Overview
Compare
Fundraising
Employees
Website

Elixir Medical Corporation, headquartered in Sunnyvale, California, is dedicated to developing advanced medical devices and pharmaceuticals aimed at providing effective cardiovascular treatments. The company's core products include next-generation drug-eluting stent systems designed to optimize localized drug delivery, enhancing the safety and efficacy of treatments for cardiovascular patients. Their market focus is on improving outcomes for individuals suffering from coronary artery disease.

Elixir Medical has achieved significant milestones, including the FDA Breakthrough Device Designation for its DynamX Sirolimus-Eluting Coronary Bioadaptor System. This recognition underscores the innovative nature of their technology and its potential to offer superior treatment options for symptomatic ischemic heart disease. The bioadaptor system aims to improve coronary luminal diameter, restore hemodynamic modulation, and reduce plaque progression, marking a notable impact in the field of cardiovascular health.

Elixir Medical - Similar Companies

eLum Technologies logo

eLum Technologies

Endologix logo

Endologix

endologix.com

Cardiac Dimensions logo

Cardiac Dimensions

East End Medical logo

East End Medical

Svelte Medical Systems logo

Svelte Medical Systems

Edwards Lifesciences logo

Edwards Lifesciences

edwards.com

Phoenix Cardiac logo

Phoenix Cardiac

Emboline logo

Emboline

VytronUS logo

VytronUS

Concept Medical logo

Concept Medical

conceptmedical.com

Adagio Medical logo

Adagio Medical

Vascular Designs logo

Vascular Designs

Elex Biotech logo

Elex Biotech

eLux Medical logo

eLux Medical

Cross Vascular logo

Cross Vascular

Elixir Medical - Quick Facts

Who are Elixir Medical's competitors?

Companies similar to Elixir Medical include eLum Technologies, Endologix, Cardiac Dimensions and East End Medical.

When was Elixir Medical founded?

Elixir Medical was founded in 2004.

Where is Elixir Medical's headquarters located?

Elixir Medical's headquarters is located in Sunnyvale, CA, US.

When was Elixir Medical's last funding round?

Elixir Medical's most recent funding round was for $5.3M (USD) in March 2005.

How much has Elixir Medical raised to-date?

As of Mar 18, 2005, Elixir Medical has raised a total of $5.3M (USD).

How many employees does Elixir Medical have?

Elixir Medical has 75 employees as of Feb 4, 2024.

Elixir Medical - Classification

Industry
  • Hardware
Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Software
Customer
  • Enterprise
  • Government
Main Product
  • Medical Devices
Tags
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified